Extreme hyperbilirubinemia associated with the use of anabolic steroids, health/nutritional supplements, and ethanol: Response to ursodeoxycholic acid treatment

American Journal of Gastroenterology

Volumn 91, Issue 4, 1996, Pages 783-785

  Singh, Charnjit ^a   Bishop, Philippe ^a   Willson, Richard ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANDROLONE DECANOATE; STANOZOLOL;

ADULT; ARTICLE; ATHLETE; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DRUG TOXICITY; HERBAL MEDICINE; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; MALAISE; MALE; NAUSEA; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; PRURITUS;

ADULT; ANABOLIC AGENTS; BEER; FOOD, FORTIFIED; HEALTH FOOD; HUMANS; HYPERBILIRUBINEMIA; MALE; NANDROLONE; PHYTOTHERAPY; STANOZOLOL; URSODEOXYCHOLIC ACID; WEIGHT LIFTING;

EID: 0029870050     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Yesalis CE, Kennedy NJ, Kopstein AN, et al. Anabolic androgenic steroid use in the United States. JAMA 1993;270:1217-21.
2. Ishak KG, Zimmerman HJ. Hepatotoxic effects of the anabolic/androgenic steroids. Semin Liver Dis 1987;7:230-6.
3. Fulop M, Katz S, Lawrence C. Extreme hyperbilirubinemia. Arch Intern Med 1971;127:254-8.
4. Evely RS, Triger DR, Milnes JP, et al. Severe cholestasis associated with stanozolol. Br Med J 1987;294:612-3.
5. Yoshida EM, Karim MA, Shaikh JF, et al. At what price glory? Severe cholestasis and acute renal failure in an athlete abusing stanozolol. Can Med Assoc J 1994;151:791-3.
6. Abt AB, Oh JY, Huntington RA, et al. Chinese herbal medicine induces acute renal failure. Arch Intern Med 1995;155:211-2.
7. Westaby D, Ogle SJ, Paradinas PJ. Liver damage from long-term methyltestosterone. Lancet 1977;2:262-3.
8. Lindstrom M, Nilsson AL, Katzman PL, et al. Use of anabolic-androgenic steroids among body builders: Frequency and attitudes. J Intern Med 1990;227:407-11.
9. Koff RS. Herbal hepatotoxicity. Revisiting a dangerous alternative. JAMA 1995;273:502.
10. Eisenberg DM, Kessler RC, Foster C, et al. Unconventional medicine in the United States. Prevalence, costs and patterns of use. N Engl J Med 1993;328:246-52.
11. Espinoza EO, Mann MJ, Bleasdell B. Arsenic and mercury in traditional Chinese herbal balls. N Engl J Med 1995;333:803-4.
12. +-gradient. Am J Physiol 1983;245:G399-G403.
13. Quigley EMM, Marsh MN, Shaffer JL, et al. Hepatobiliary complications of total parenteral nutrition. Gastroenterology 1993;104:286-301.
14. Mills PR, Meier PJ, Smith DJ, et al. The effect of changes in the fluid state of rat liver plasma membrane on the transport of taurocholate. Hepatology 1987;7:61-6.
15. Alvaro D, Benedetti A, Gigliozzi A, et al. Functional and ultrastructural features of ethanol/bile salts interactions in the isolated perfused rat liver. Hepatology 1995;21:1120-9.
16. Botla R, Spivey JR, Aguilar H, et al. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: A mechanism of UDCA cytoprotection. J Pharmacol Exp Ther 1995;272:930-8.
17. Poupon RE, Poupon R, Balkau B, et al. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-7.